International Society of Innovative Technologies for Endocrine Surgery (EIN 873213333) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

Frederic Triponez

Phone

3122025437

Tax Period

2022-07-01 to 2023-06-30

International Society of Innovative Technologies for Endocrine Surgery, founded in 2021, is a micro nonprofit in the Diseases & Disorders sector that reported $3K in total revenue in fiscal year 2022. Revenue fell 96% from the prior year — a significant decline worth monitoring. Expenses of $11K exceeded revenue, resulting in a 227% operating deficit.

Mission

The purpose of the Society shall be to: (1) Promote research in new technologies that advance our understanding of the human endocrine system, including anatomy, physiology and pathology. (2) Disseminate the appropriate and responsible use of such new technologies. (3) Advance the care of patients with endocrine surgical diseases.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $3,300

Investment Income $0

Other Revenue $0

TOTAL REVENUE $3,300

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $10,788

TOTAL EXPENSES $10,788

Year-over-Year Comparison

	2022	2021	Change
Revenue	$3,300	$85,816	-1.0%
Expenses	$10,788	$123,949	-0.9%
Net Income	$-7,488	$-38,133	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Frederic Triponez	President	1.00	Officer Director	$0	$0	$0
Quan-Yang Duh	Secretary	1.00	Officer Director	$0	$0	$0
Anita Mahadevan-Jansen	Treasurer	1.00	Officer Director	$0	$0	$0
Jaepyeong Cha	Council Member	1.00	Director	$0	$0	$0
Kerstin Lorenz	Council Member	1.00	Director	$0	$0	$0
Saba Balasubramanian	Council Member	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$3,300	$10,788	$9,159	$-7,488
2022	$85,816	$123,949	$55,220	$-38,133

International Society of Innovative Technologies for Endocrine Surgery